Publications dans lesquelles il/elle collabore avec LUIS CARLOS JIMÉNEZ ROMERO (38)

2023

  1. Modified Chevrel technique for abdominal closure in critically ill patients with abdominal hypertension and limited options for closure

    Hernia, Vol. 27, Núm. 3, pp. 677-685

  2. Pyogenic liver abscesses in liver transplant recipients versus non-transplant population. Outcome and risk factors of patient survival

    Clinical Transplantation, Vol. 37, Núm. 6

  3. Risk factors indicating the need for surgical therapy in patients with pyogenic liver abscesses

    Langenbeck's Archives of Surgery, Vol. 408, Núm. 1

  4. Risk factors of massive blood transfusion in liver transplantation: consequences and a new index for prediction including the donor

    Cirugia Espanola, Vol. 101, Núm. 10, pp. 684-692

2022

  1. Expanding donor age in liver transplantation using liver grafts from nonagenarian donors

    Clinical Transplantation, Vol. 36, Núm. 7

  2. Liver Transplantation in Sexagenarian Patients Using Grafts From Uncontrolled Circulatory Death Versus Grafts From Brain Death Donation

    Transplantation Proceedings, Vol. 54, Núm. 7, pp. 1839-1846

  3. Modifications in Abdominal Wall Graft Retrieval: When the Donor Closure Is Not Guaranteed

    Transplantation Proceedings, Vol. 54, Núm. 9, pp. 2422-2426

  4. New technique for abdominal wall procurement. Initial experience

    Clinical Transplantation, Vol. 36, Núm. 2

  5. Short series regarding uncontrolled donor after cardiac death: A call for caution

    Clinical Transplantation

2021

  1. Authors’ response to Cai et al. on their commentary on “Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals” (Int J Surg 2021, 106096)

    International Journal of Surgery

  2. Estado actual del trasplante de páncreas. Experiencia del hospital Doce de Octubre

    Anales de la Real Academia Nacional de Medicina, Núm. 138, pp. 157-167

  3. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794

  4. Validation of McCluskey Index for Massive Blood Transfusion Prediction in Liver Transplantation

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2698-2701

2019

  1. Morbidly Obese Patients Awaiting Liver Transplantation—Sleeve Gastrectomy: Safety and Efficacy From a Liver Transplant Unit Experience

    Transplantation Proceedings, Vol. 51, Núm. 1, pp. 33-37

  2. Uso de la octreótida en ascitis refractaria después de un trasplante hepático

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 11, pp. 882-884

2018

  1. Análisis retrospectivo en pacientes con cáncer de vesícula biliar: tratamiento quirúrgico y supervivencia en función del estadio tumoral

    Revista Española de Enfermedades Digestivas, Vol. 110, Núm. 8, pp. 485-492

  2. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  3. Trasplante hepatorrenal simultáneo en pacientes adultos con hiperoxaluria primaria: Experiencia del Hospital Universitario 12 de Octubre

    Revista Española de Enfermedades Digestivas, Vol. 110, Núm. 2, pp. 82-87

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 695-701